President Donald Trump's order to reclassify cannabis as a Schedule 3 drug is a huge step forward - but operators must know its limits.

Cannabis will be moved to Schedule 3 of the Controlled Substances Act under an executive order President Donald Trump signed ...

The number of active cannabis cultivation permits in the U.S. dropped by 24% since 2023, an ongoing pullback that's a sign of ...

New Jersey legislators are moving forward with a bill that could reshape the state’s market for hemp-derived cannabinoids.

A partnership between High Times and Hoodie Analytics gives retailers and brands increased visibility on the publication’s ...

Cannabis MSO PharmaCann is selling some of its Colorado retail assets to Vireo Growth Inc. for $49 million in newly issued ...

If the reaction from conservative pundits and MAGA world figures is any indication, President Donald Trump will reclassify ...

The Maine cannabis industry would become medical-only - and with strict new rules - if a ballot initiative campaign is ...

Cannabis and hemp THC companies stand to benefit if marijuana is reclassified to Schedule 3, but banking and investment needs ...

Kentucky’s first medical marijuana dispensary opened nearly a year after the first patients received MMJ cards.

President Donald Trump's executive order reclassifying cannabis as a Schedule 3 drug could come Monday - and with it, Medicare coverage for CBD.

Cannabis prices are falling in Connecticut but still remain double bordering Massachusetts. Overall sales are also declining, data shows.